Literature DB >> 1153938

Endoscopic papillotomy. Experimental studies and initial clinical experience.

H Koch, M Classen, O Schaffner, L Demling.   

Abstract

Experimental studies carried out in 11 dogs have shown that, with the aid of a high frequency diathermy probe, satisfactory papillotomies can be performed. On the basis of these results, endoscopic papillotomies have been carried out in 23 patients. Indications for papillotomy were biliary calculi in 11 high-risk patients, in 6 cases calculi overlooked during bile duct surgery, and in 3 patients recurrent calculi after previous cholecystectomy. In 3 patients circumscribed papillary stenosis indicated endoscopic papillotomy. Papillotomy was successful in all 23 cases. In 9 cases the calculi had been passed spontaneously after 3-5 days. In 10 patients the stones had to be extracted using the Dormia basket or a wire loop, and in one patient the stone had to be removed surgically. In one of these patients endoscopic papillotomy was followed by an attack of pancreatitis which subsided after 3 days. Further complications, in particular the occurrence of massive bleeding after papillotomy, were not observed.

Entities:  

Mesh:

Year:  1975        PMID: 1153938

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  4 in total

Review 1.  Biliary concrements: the endoscopic approach.

Authors:  A R Rosseland; M Osnes
Journal:  World J Surg       Date:  1989 Mar-Apr       Impact factor: 3.352

Review 2.  ERCP.

Authors:  P B Cotton
Journal:  Gut       Date:  1977-04       Impact factor: 23.059

3.  Endoscopic retrograde sphincterotomy in swine.

Authors:  C F Gholson; J M Provenza; J T Doyle; B R Bacon
Journal:  Dig Dis Sci       Date:  1991-10       Impact factor: 3.199

4.  Endoscopic sphincteropapillotomy: an analysis of 108 cases.

Authors:  J B Choi; Y C Yang; J R Han; P K Jeong; S H Ha; H S Yeo; H B Park
Journal:  Korean J Intern Med       Date:  1986-07       Impact factor: 2.884

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.